Literature DB >> 33483356

Individual non-esterified fatty acids and incident atrial fibrillation late in life.

Cara N Pellegrini1,2, Petra Buzkova3, Alice H Lichtenstein4, Nirupa R Matthan4, Joachim H Ix5, David S Siscovick6, Susan R Heckbert7, Russell P Tracy8, Kenneth J Mukamal9, Luc Djoussé10, Jorge R Kizer11,2.   

Abstract

OBJECTIVE: Obesity and dysmetabolism are major risk factors for atrial fibrillation (AF). Expansion of fat depots is associated with increased circulating total non-esterified fatty acids (NEFAs), elevated levels of which are associated with incident AF. We undertook comprehensive serum measurement of individual NEFA to identify specific associations with new-onset AF late in life.
METHODS: The present study focused on participants with available serum and free of AF selected from the Cardiovascular Health Study, a community-based longitudinal investigation of older US adults. Thirty-five individual NEFAs were measured by gas chromatography. Cox regression was used to evaluate the association of individual NEFAs with incident AF.
RESULTS: The study sample included 1872 participants (age 77.7±4.4). During median follow-up of 11.3 years, 715 cases of incident AF occurred. After concurrent adjustment of all NEFAs and full adjustment for potential confounders, higher serum concentration of nervonic acid (24:1 n-9), a long-chain monounsaturated fatty acid, was associated with higher risk of AF (HR per SD: 1.18, 95% CI 1.08 to 1.29; p<0.001). Conversely, higher serum concentration of gamma-linolenic acid (GLA) (18:3 n-6), a polyunsaturated n-6 fatty acid, was associated with lower risk of AF (HR per SD: 0.81, 95% CI 0.71 to 0.94; p=0.004). None of the remaining NEFAs was significantly associated with AF.
CONCLUSIONS: Among older adults, serum levels of non-esterified nervonic acid were positively associated, while serum levels of non-esterified GLA were inversely associated, with incident AF. If confirmed, these results could offer new strategies for AF prevention and early intervention in this segment of the population at highest risk. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  atrial fibrillation; epidemiology; metabolic syndrome

Mesh:

Substances:

Year:  2021        PMID: 33483356      PMCID: PMC8607526          DOI: 10.1136/heartjnl-2020-317929

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study.

Authors:  Ingeborg A Brouwer; Jan Heeringa; Johanna M Geleijnse; Peter L Zock; Jacqueline C M Witteman
Journal:  Am Heart J       Date:  2006-04       Impact factor: 4.749

Review 2.  Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes.

Authors:  Susan Sergeant; Elaheh Rahbar; Floyd H Chilton
Journal:  Eur J Pharmacol       Date:  2016-04-12       Impact factor: 4.432

3.  Plasma free fatty acids and risk of atrial fibrillation (from the Cardiovascular Health Study).

Authors:  Owais Khawaja; Traci M Bartz; Joachim H Ix; Susan R Heckbert; Jorge R Kizer; Susan J Zieman; Kenneth J Mukamal; Russell P Tracy; David S Siscovick; Luc Djoussé
Journal:  Am J Cardiol       Date:  2012-04-12       Impact factor: 2.778

4.  Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes.

Authors:  Y Li; J X Kang; A Leaf
Journal:  Prostaglandins       Date:  1997-08

5.  Individual omega-9 monounsaturated fatty acids and mortality-The Ludwigshafen Risk and Cardiovascular Health Study.

Authors:  Graciela E Delgado; Bernhard K Krämer; Stefan Lorkowski; Winfried März; Clemens von Schacky; Marcus E Kleber
Journal:  J Clin Lipidol       Date:  2016-11-10       Impact factor: 4.766

6.  Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study.

Authors:  G S Tell; L P Fried; B Hermanson; T A Manolio; A B Newman; N O Borhani
Journal:  Ann Epidemiol       Date:  1993-07       Impact factor: 3.797

Review 7.  Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.

Authors:  Carl J Lavie; Ambarish Pandey; Dennis H Lau; Martin A Alpert; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2017-10-17       Impact factor: 24.094

Review 8.  Biosynthesis of nervonic acid and perspectives for its production by microalgae and other microorganisms.

Authors:  Yong Fan; Hui-Min Meng; Guang-Rong Hu; Fu-Li Li
Journal:  Appl Microbiol Biotechnol       Date:  2018-02-24       Impact factor: 4.813

Review 9.  Fat depots, free fatty acids, and dyslipidemia.

Authors:  Jon O Ebbert; Michael D Jensen
Journal:  Nutrients       Date:  2013-02-07       Impact factor: 5.717

10.  Tissue-specific impact of FADS cluster variants on FADS1 and FADS2 gene expression.

Authors:  Lindsay M Reynolds; Timothy D Howard; Ingo Ruczinski; Kanika Kanchan; Michael C Seeds; Rasika A Mathias; Floyd H Chilton
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

View more
  1 in total

1.  Correlation between Cardiac Ultrasound Index and Cardiovascular Risk in Healthy Obese and Overweight Populations.

Authors:  Xiaoyu Pan; Xiaoyi Chen; Lin Ren; Zelin Li; Shuchun Chen
Journal:  Int J Clin Pract       Date:  2022-09-21       Impact factor: 3.149

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.